Qui Tam Seminars


Watch Now
  • “National Whistleblower Litigation: Qui Tam, False Claims Act, Dodd-Frank and Tax Cases,” by Joel Androphy. 4 Video Collection. Watch Now.
  • “Inside the Defense of the Lindsey Manufacturing, Africa Sting, and O’Shea Prosecutions: What Recent Cases Reveal About the Future of FCPA Enforcement Against Individuals,” 28th National Conference on the Foreign Corrupt Practices Act, November 15, 2012
  • KPMG Anti-Bribery and Corruption Share Forum, Houston, Texas, June 25, 2012
  • “The Whistleblowers Among Us: The Implications of the Dodd-Frank Act and Other Government Whistleblower Programs,” ABA National Institute on Internal Corporate Investigations and Forum for In-House Counsel, May 18, 2012
  • “The Trial of a Health Care Fraud Case: Trial Practice Demonstration,” ABA National Institute on Health Care Fraud, May 11, 2012
  • “Quality of Care: The New Frontier of Health Care Fraud Enforcement,” ABA Webinar, May 3, 2012
  • “Parlez-vous Kickback? – The Application of the Foreign Corrupt Practices Act to the Healthcare Arena,” ABA 13th Annual Conference on Emerging Issues in Healthcare Law, San Diego, February 22, 2012
  • “The Trial of a Foreign Corrupt Practices Case,” Houston Bar Association Securities Law Section, February 14, 2012
  • “How Will Investigations and Lawsuits Arising Under the Qui Tam Provisions of the False Claims Act Affect You and Your Company,” 11th Annual Conference on Emerging Issues in Healthcare Law, ABA, February 18, 2010
  • “Qui Tam Prosecutions,” United States Attorney’s Office, Southern District of Texas, Federal Prosecutors’ Seminar, September 22, 2009
  • “Qui Tam Claims: The Whistleblower Employee Teaming up with the Federal Government,” South Texas College of Law, July 17, 2009 (materials only)
  • “Qui Tam Practice,” Emerging Trends in Litigation,” State Bar of Texas, Padre Island, May 1, 2009
  • “National Pharma Audioconference: Lessons of Eli Lilly’s $1.4 Billion Off Label Zyprexa Settlement,” March 24, 2009
  • “Trends in White Collar Crime,” Houston Commercial Finance Lawyer’s Forum, March 3, 2009
  • “Battling Health Care Fraud: Criminal and Civil Perspectives,” West Webinar, December 18, 2008
  • “False Claims Act and Qui Tam Litigation,” Commercial Litigation Program, Texas Trial Lawyers Association, Austin, December 3, 2008
  • “Prosecuting and Defending Qui Tam Cases Under the False Claims Act: What it Takes to be Successful,” Law Journal Newsletters and Webinar, November 11, 2008
  • “Qui Tam Lawsuits and Whistleblowers,” White Collar Practice for the Business Lawyer and In-House Counsel, South Texas College of Law, July 31, 2008
  • “White Collar Crime and Qui Tam Cases,” State Bar of Texas, In House Counsel Course, July 24, 2008
  • “White Collar Crime and Qui Tam Cases,” International Association of Defense Counsel, Greenbriar, July 5, 2008
  • “White Collar Crime and Qui Tam Cases,” State Bar Annual Meeting, June 27, 2008
  • “White Collar Crime and Qui Tam Litigation,” Federal Bar Association, May 15, 2008
  • ”Off-Label Promotion,” Food and Drug Law Institute’s Fifth Annual Enforcement and Litigation Conference, February 5, 2007
  • “Off -Label Qui Tam Lawsuits: How to Avoid Them and What to Do if You Get Sued,” Fifth Annual Off-Label Usage Conference, Pharmaceutical Education Associates, September 20 – 21, 2006 (Chair of the Seminar and Moderator on several panels)
  • “What Pharmaceutical Companies Need to Know About Preventing and Dealing with Qui Tam Cases: Kickbacks, Off-Label Marketing Violations, and Other Crimes,” Pharmaceutical Education Associates, September 21, 2004, Philadelphia, Pennsylvania
  • “White Collar Crime/Qui Tam for Health Care Facilities,” Houston Bar Association, Health Care Section, Houston, January 14, 2004
  • “Whistleblower and Qui Tam Litigation, Advanced In-House Counsel Course,” State Bar of Texas, San Antonio, Texas, August 14, 2003
  • “Qui Tam Litigation, Fraud and False Claims,” American Health Lawyer’s Association, San Antonio, Texas, July 1, 2003
  • “Whistleblower and Qui tam Litigation: Suing the Corporation for Fraud,” White Collar Crime Conference, State Bar of Texas Annual Meeting, June 13, 2003, Houston, Texas
  • “Whistleblower and Qui tam Litigation: Suing the Corporation for Fraud,” Business Crimes and Civil Responsibility, South Texas College of Law, April 11, 2003, Houston, Texas
  • ”Lifting the Veil of Sarbanes-Oxley,” NASDAQ sponsored program along with Jackson Walker and PricewaterhouseCoopers, December 5, Houston, Texas, December 6, Dallas, Texas
  • “Qui Tam Litigation,” Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum, November 15, 2002, Philadelphia, Pennsylvania
  • “Qui Tam Litigation – Suing the corporation, a Whistleblower’s Jackpot,” White Collar Crime for the Civil Practitioner, State Bar of Texas, November 14 – 15, 2002

For more information, email quitam@bafirm.com


This website is designed to provide general information only. This information is not and should not be construed to be legal advice. The transmission of the information found on this website also does not result in the formation of a lawyer-client relationship.

You should be aware that qui tam claims are subject to a Statute of Limitations. The area of limitations periods is complex. There are also first to file rules, public disclosure bars, original source issues, and varying limitations in pursuing retaliation claims. If you wish to pursue your claims, you should promptly seek the opinion of an attorney regarding the merits of your qui tam claim and the applicable statute of limitations.